Literature DB >> 26113559

Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression.

Ying Qin1, He Cui2, Hua Zhang3.   

Abstract

Lung cancer is one of the most common causes of cancer-related deaths worldwide. Although great efforts and progressions have been made in the study of the lung cancer in the recent decades, the mechanism of lung cancer formation remains elusive. To establish effective therapeutic methods, new targets implied in lung cancer processes have to be identified. Tripartite motif-containing 25 has been associated with ovarian and breast cancer and is thought to positively promote cell growth by targeting the cell cycle. However, whether tripartite motif-containing 25 has a function in lung cancer development remains unknown. In this study, we found that tripartite motif-containing 25 was overexpressed in human lung cancer tissues. Expression of tripartite motif-containing 25 in lung cancer cells is important for cell proliferation and migration. Knockdown of tripartite motif-containing 25 markedly reduced proliferation of lung cancer cells both in vitro and in vivo and reduced migration of lung cancer cells in vitro Meanwhile, tripartite motif-containing 25 silencing also increased the sensitivity of doxorubicin and significantly increased death and apoptosis of lung cancer cells by doxorubicin were achieved with knockdown of tripartite motif-containing 25. We also observed that tripartite motif-containing 25 formed a complex with p53 and mouse double minute 2 homolog (MDM2) in both human lung cancer tissues and in lung cancer cells and tripartite motif-containing 25 silencing increased the expression of p53. These results provide evidence that tripartite motif-containing 25 contributes to the pathogenesis of lung cancer probably by promoting proliferation and migration of lung cancer cells. Therefore, targeting tripartite motif-containing 25 may provide a potential therapeutic intervention for lung cancer.
© The Author(s) 2015.

Entities:  

Keywords:  NSCLC; RNAi; lentivirus; lung cancer esophageal cancer; shRNA

Mesh:

Substances:

Year:  2015        PMID: 26113559     DOI: 10.1177/1533034615595903

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  18 in total

1.  DeSUMOylation switches Kaiso from activator to repressor upon hyperosmotic stress.

Authors:  Svetlana Zhenilo; Igor Deyev; Ekaterina Litvinova; Nadezhda Zhigalova; Daria Kaplun; Alexey Sokolov; Alexander Mazur; Egor Prokhortchouk
Journal:  Cell Death Differ       Date:  2018-02-22       Impact factor: 15.828

Review 2.  The roles of E3 ligases in Hepatocellular carcinoma.

Authors:  Zongdong Yu; Hong Li; Jie Zhu; Haibiao Wang; Xiaofeng Jin
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

3.  The MAP3K13-TRIM25-FBXW7α axis affects c-Myc protein stability and tumor development.

Authors:  Qiang Zhang; Xu Li; Kasa Cui; Cheng Liu; Mingzhi Wu; Edward V Prochownik; Youjun Li
Journal:  Cell Death Differ       Date:  2019-06-11       Impact factor: 15.828

4.  TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability.

Authors:  Sha Zhou; Jianhong Peng; Liuniu Xiao; Caixia Zhou; Yujing Fang; Qingjian Ou; Jiayi Qin; Mengzhong Liu; Zhizhong Pan; Zhenlin Hou
Journal:  Cell Death Dis       Date:  2021-05-08       Impact factor: 8.469

5.  TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells.

Authors:  Xiaolin Wang; Weiping Shi; Hongcan Shi; Shichun Lu; Kang Wang; Chao Sun; Jiansheng He; Weiguo Jin; Xiaoxia Lv; Hui Zou; Yusheng Shu
Journal:  J Exp Clin Cancer Res       Date:  2016-06-21

6.  TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling.

Authors:  Zhenya Zhu; Yong Wang; Chunhui Zhang; Shiyong Yu; Qi Zhu; Kun Hou; Bo Yan
Journal:  Sci Rep       Date:  2016-01-12       Impact factor: 4.379

7.  Tripartite motif containing 25 promotes proliferation and invasion of colorectal cancer cells through TGF-β signaling.

Authors:  Nianfeng Sun; Yu Xue; Ting Dai; Xiding Li; Nanxiang Zheng
Journal:  Biosci Rep       Date:  2017-07-12       Impact factor: 3.840

Review 8.  TRIM25 in the Regulation of the Antiviral Innate Immunity.

Authors:  María Martín-Vicente; Luz M Medrano; Salvador Resino; Adolfo García-Sastre; Isidoro Martínez
Journal:  Front Immunol       Date:  2017-09-22       Impact factor: 7.561

9.  Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.

Authors:  Wataru Sato; Kazuhiro Ikeda; Tomohiko Urano; Yayoi Abe; Norie Nakasato; Kuniko Horie-Inoue; Satoru Takeda; Satoshi Inoue
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

10.  TRIM56 Suppresses Multiple Myeloma Progression by Activating TLR3/TRIF Signaling.

Authors:  Ying Chen; Jing Zhao; Dengzhe Li; Jinxia Hao; Pengcheng He; Huaiyu Wang; Mei Zhang
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.